Pharmaceutical

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.

Jul 10, 2024 - 04:00
Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.
Read the original article

Tags:

Previous Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Next Article

Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Newly launched Calluna raises $81m to advance monoclonal antibody pipeline

Newly launched Calluna raises $81m to advance monoclona...

Jan 23, 2024

Opinion: How to save the U.S. News & World Report Best Hospitals rankings

Opinion: How to save the U.S. News & World Report Best ...

Aug 25, 2023

STAT+: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers

STAT+: Neuralink can now study its brain implant in hum...

May 27, 2023